Toll Free: 1-888-928-9744

Synta Pharmaceuticals Corp. - Product Pipeline Review - 2015

Published: Jul, 2015 | Pages: 52 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Synta Pharmaceuticals Corp. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'Synta Pharmaceuticals Corp. - Product Pipeline Review - 2015', provides an overview of the Synta Pharmaceuticals Corp.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Synta Pharmaceuticals Corp.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Synta Pharmaceuticals Corp. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Synta Pharmaceuticals Corp.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Synta Pharmaceuticals Corp.'s pipeline products

Reasons to buy

- Evaluate Synta Pharmaceuticals Corp.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Synta Pharmaceuticals Corp. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Synta Pharmaceuticals Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Synta Pharmaceuticals Corp. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Synta Pharmaceuticals Corp.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of Synta Pharmaceuticals Corp. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Synta Pharmaceuticals Corp. Snapshot 5 Synta Pharmaceuticals Corp. Overview 5 Key Information 5 Key Facts 5 Synta Pharmaceuticals Corp. - Research and Development Overview 6 Key Therapeutic Areas 6 Synta Pharmaceuticals Corp. - Pipeline Review 10 Pipeline Products by Stage of Development 10 Pipeline Products - Monotherapy 11 Synta Pharmaceuticals Corp. - Pipeline Products Glance 12 Synta Pharmaceuticals Corp. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Synta Pharmaceuticals Corp. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Synta Pharmaceuticals Corp. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Synta Pharmaceuticals Corp. - Drug Profiles 17 ganetespib 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 elesclomol 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Small Molecule to Inhibit HSP90 for Inflammation 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecules to Block CRACM Channel for Inflammation and Rheumatoid Arthritis 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 STA-128666 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 STA-129183 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 STA-2842 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Small Molecule to Inhibit IL 12/IL 23 for Autoimmune Disorders and Inflammation 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Synta Pharmaceuticals Corp. - Pipeline Analysis 31 Synta Pharmaceuticals Corp. - Pipeline Products by Target 31 Synta Pharmaceuticals Corp. - Pipeline Products by Route of Administration 32 Synta Pharmaceuticals Corp. - Pipeline Products by Molecule Type 33 Synta Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action 34 Synta Pharmaceuticals Corp. - Recent Pipeline Updates 35 Synta Pharmaceuticals Corp. - Dormant Projects 45 Synta Pharmaceuticals Corp. - Discontinued Pipeline Products 46 Discontinued Pipeline Product Profiles 46 apilimod mesylate 46 Synta Pharmaceuticals Corp. - Company Statement 47 Synta Pharmaceuticals Corp. - Locations And Subsidiaries 50 Head Office 50 Other Locations & Subsidiaries 50 Appendix 51 Methodology 51 Coverage 51 Secondary Research 51 Primary Research 51 Expert Panel Validation 51 Contact Us 51 Disclaimer 52
List of Tables
Synta Pharmaceuticals Corp., Key Information 5 Synta Pharmaceuticals Corp., Key Facts 5 Synta Pharmaceuticals Corp. - Pipeline by Indication, 2015 7 Synta Pharmaceuticals Corp. - Pipeline by Stage of Development, 2015 10 Synta Pharmaceuticals Corp. - Monotherapy Products in Pipeline, 2015 11 Synta Pharmaceuticals Corp. - Phase III, 2015 12 Synta Pharmaceuticals Corp. - Phase II, 2015 13 Synta Pharmaceuticals Corp. - Phase I, 2015 14 Synta Pharmaceuticals Corp. - Preclinical, 2015 15 Synta Pharmaceuticals Corp. - Discovery, 2015 16 Synta Pharmaceuticals Corp. - Pipeline by Target, 2015 31 Synta Pharmaceuticals Corp. - Pipeline by Route of Administration, 2015 32 Synta Pharmaceuticals Corp. - Pipeline by Molecule Type, 2015 33 Synta Pharmaceuticals Corp. - Pipeline Products by Mechanism of Action, 2015 34 Synta Pharmaceuticals Corp. - Recent Pipeline Updates, 2015 35 Synta Pharmaceuticals Corp. - Dormant Developmental Projects,2015 45 Synta Pharmaceuticals Corp. - Discontinued Pipeline Products, 2015 46 Synta Pharmaceuticals Corp., Other Locations 50 Synta Pharmaceuticals Corp., Subsidiaries 50



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify